A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion
PHASE4
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses
PHASE2
The purpose of this study is to investigate the efficacy and safety of Lenv...
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
N/A
The system assesses the heterogeneity of HCC patients in terms of therapeut...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Hainan Medical Universsity
Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors
PHASE2
This is a monocenter, single-arm, open-label study to evaluate the efficacy...